Clinical Trial

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Study acronym: ProBOLIC
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This randomized, active-controlled, parallel-arm, single-blind trial is to compare the effects of Dopamine agonists (DA) therapy targeting different established treatment strategies on glucose metabolism assessed by an oral glucose tolerance test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-23.
Trial Details
NCT Number NCT07045935
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Prolactinoma
Enrollment 60 participants
Start Date 2025-09-16
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23